Marianna Castellanos Fernandez

Mrs. Marianna Castellanos Fernandez

Universidad de La Sabana. Km 7, Autopista Norte de Bogotá, Chía – Colombia.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2020 in Preprints.org
Verified
Preprint
Open access
PDF file
AVAdriana Vargas-Niño
Adriana Vargas-Niño
JRJorge Rojas-Martinez
Jorge Rojas-Martinez
Ivan AivasovskyIvan Aivasovsky
Ivan Aivasovsky
SCSergio Vergara Cardenas
Sergio Vergara Cardenas
MFMarianna Castellanos Fernandez
Marianna Castellanos Fernandez
LCLuis G. Celis-Regalado
Luis G. Celis-Regalado
The KARS gene encodes the aminoacyl-tRNA synthetase (aaRS) which activates and joins the lysin with its corresponding transfer RNA (tRNA), through the ATP-dependent aminoacylation of the amino acid. The KARS gene mutations have been linked to diverse neurologic phenotypes such as: neurosensorial hearing loss, leukodistrophy, microcephaly, developmental delay or regression, peripheral neuropathy, cardiomyopathy, impairment of the mitochondrial respiratory chain, hyperlactatemia, among others. This article presents the case of a Colombian pediatric patient with two pathological missense variants in a compound heterozygous state in the KARS gene.

25 September 2020 in Revista Nova publicación científica en ciencias biomédicas
Verified
Journal Article
Open access
PDF file
GNGina Nieto-Duarte
Gina Nieto-Duarte
PPPatricia Pichilingue
Patricia Pichilingue
Ivan AivasovskyIvan Aivasovsky
Ivan Aivasovsky
MFMarianna Castellanos Fernandez
Marianna Castellanos Fernandez
LRLuis Gustavo Celis Regalado
Luis Gustavo Celis Regalado
In the context of the COVID-19 pandemic, the adequate selection and appropriate use of previously acquired knowledge from similar historical situations and the one acquired lately amid the pandemic is vital to guarantee correct decision-making regarding the prevention, management and treatment of this disease in the pediatric population. Since the beginning of 2020, attention has shifted to controlling the pandemic and managing patients with this disease, the majority being those in the adult population. However, more severe courses of the disease have recently been observed in pediatric patients, and what was initially considered to be a harmless pathology in this population has generated greater alerts due to the presence of severe complications. Therefore, this review seeks to determine the latest prevention, diagnosis and treatment strategies endorsed and supported by scientific evidence, in order to provide the necessary tools to guarantee proper management and to reduce, as far as possible, the fatal outcomes in the pediatric population. En el contexto de la pandemia por COVID-19, es importante la selección y el uso adecuado de los conocimientos nuevos y de aquellos adquiridos en situaciones históricas similares, para garantizar una correcta toma de decisiones en cuanto a la prevención, manejo y tratamiento de esta enfermedad en la población pediátrica. Desde inicios del 2020, la atención se ha focalizado en el control de la pandemia y en el manejo de los pacientes con esta enfermedad, cuya mayoría se encuentra en la población adulta. Sin embargo, recientemente se han observado cursos más severos de la enfermedad en pacientes pediátricos y lo que inicialmente se consideraba como una patología inofensiva ha generado mayores alertas en esta población por la presencia de complicaciones severas. Por lo anterior, la presente revisión busca determinar las últimas estrategias de prevención, diagnóstico y tratamiento avaladas y soportadas por la evidencia científica, de manera que se aporten las herramientas necesaria para garantizar un manejo adecuado y disminuir, en la medida de lo posible, los desenlaces fatales en la población pediátrica.